Related Topics
New TB vaccine could produce large health, economic benefits in LMICs
Introducing an effective new tuberculosis vaccine in low- and middle-income countries could lead to billions of dollars in potential health and economic benefits, according to a modeling study led by Harvard Chan School.
Report makes the case for new TB vaccines
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment, according to a new report.
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Project uses geographic data to show that where a person lives matters to their health
Harvard Chan School's Nancy Krieger and colleagues have updated and broadened a project aimed at training people in how to track and monitor socially related disparities having to do with where a person lives.
A better antibiotic for tuberculosis treatment
PhD candidate Harim Won is developing a new type of antibiotic to address long-standing issues of lengthy treatments and drug resistance, using a new approach to turn a normal protein system in the bacterial cell against itself.
Both rich and poor countries saw essential health services decline during COVID
Many essential health services—including cancer and tuberculosis screenings, HIV testing, maternal health services, and child vaccinations—declined during the COVID-19 pandemic in poor and rich countries alike around the globe, according to a new study co-authored by Harvard Chan…
‘The infectious disease that nobody ever thinks about’
To mark World TB Day, March 24, Harvard Chan School's Sarah Fortune, a TB expert, discusses the state of the disease worldwide, obstacles to fighting it, and the latest research.
Eric Rubin, Renee Salas elected to National Academy of Medicine
Two researchers from Harvard T.H. Chan School of Public Health, Eric Rubin and Renee Salas, have been elected to the National Academy of Medicine.
What will it be like when COVID-19 becomes endemic?
In a Q&A, Yonatan Grad, Melvin J. and Geraldine L. Glimcher Associate Professor of Immunology and Infectious Diseases, discusses what endemic COVID-19 will look like.
The making of a disease detective
Samantha Giffen, PhD ’21, loves the thrill of discovery, in the lab and beyond May 6, 2021 – One day in 2014, Samantha Giffen sat in a small dark room at the New York State Department of Public…
